Profund Advisors LLC Eye Point Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$5.42 - $9.22 $7,159 - $12,179	-1,321 Reduced 9.61%	12,425 $67,000
Q4 2024 Feb 13, 2025	BUY	$7.02 - $12.12 $5,875 - $10,144	837 Added 6.48%	13,746 $102,000
Q3 2024 Nov 13, 2024	BUY	$7.58 - $10.54 $879 - $1,222	116 Added 0.91%	12,909 $103,000
Q2 2024 Aug 13, 2024	SELL	$8.16 - $22.89 $20,799 - $58,346	-2,549 Reduced 16.61%	12,793 $111,000
Q1 2024 May 08, 2024	BUY	$19.93 - $29.71 $305,766 - $455,810	15,342 New	15,342 $317,000

167

68M

421K

401K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $404M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.